Literature DB >> 30257372

LncRNA PRNCR1 interacts with HEY2 to abolish miR-448-mediated growth inhibition in non-small cell lung cancer.

Dezhi Cheng1, Chunchun Bao2, Xiuxing Zhang2, Xinshi Lin2, Hongou Huang2, Liang Zhao3.   

Abstract

It has been announced in accumulative studies that non-coding (nc)RNAs are responsible for a varieties of biological behaviors during the progression of tumors. As two subgroups of ncRNAs family, micro (mi)RNAs can interact with long non-coding (lnc)RNAs, thereby forming ceRNA network. In this study, miR-448 was expressed higher in NSCLC tissues (P < 0.01) and NSCLC cell lines (P < 0.01). Moreover, low expression of miR-448 predicted poor prognosis for patients with NSCLC (P < 0.001). Functional assays revealed the anti-oncogenic function of miR-448 in NSCLC by inhibiting cell proliferation, invasion, migration and epithelial-mesenchymal transition (EMT). Mechanically, miR-448 was found to be negatively regulated by lncRNA PRNCR1 (prostate cancer non-coding RNA 1). Moreover, HEY2 (Hairy and enhancer of split-related with YRPW motif protein 2) was demonstrated to be the target mRNA of miR-448 in NSCLC cells. All mechanism experiments revealed that lncRNA PRNCR1 exerted ceRNA function in NSCLC by regulating miR-448 and HEY2. To validate the function of PRNCR1-miR-488-HEY2 network in NSCLC progression, rescue assays were conducted. Taken all together, we confirmed that lncRNA PRNCR1 upregulates HEY2 to promote tumor progression in NSCLC by competitively binding miR-448.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  HEY2; NSCLC; PRNCR1; miR-448

Mesh:

Substances:

Year:  2018        PMID: 30257372     DOI: 10.1016/j.biopha.2018.08.105

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  12 in total

1.  LncRNA PCAT-1 upregulates RAP1A through modulating miR-324-5p and promotes survival in lung cancer.

Authors:  Na Huang; Wenjing Dai; Yunhui Li; Jian Sun; Chunlan Ma; Wancheng Li
Journal:  Arch Med Sci       Date:  2019-04-05       Impact factor: 3.318

2.  Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.

Authors:  Ran Guo; Tongchen Hu; Yanheng Liu; Yinzai He; Yanling Cao
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

3.  Association between polymorphisms in PRNCR1 and risk of colorectal cancer in the Saudi population.

Authors:  Mohammad AlMutairi; Narasimha Reddy Parine; Jilani Purusottapatnam Shaik; Sooad Aldhaian; Nahla A Azzam; Abdulrahman M Aljebreen; Othman Alharbi; Majid A Almadi; Amal O Al-Balbeesi; Mohammad Alanazi
Journal:  PLoS One       Date:  2019-09-05       Impact factor: 3.240

4.  lncRNA MAFG-AS1 Contributes to Esophageal Squamous-Cell Carcinoma Progression via Regulating miR143/LASP1.

Authors:  Yunhui Qu; Jinbo Liu
Journal:  Onco Targets Ther       Date:  2020-08-20       Impact factor: 4.147

5.  Differential expression of lung adenocarcinoma transcriptome with signature of tobacco exposure.

Authors:  Raneem Y Hammouz; Joanna K Kostanek; Aleksandra Dudzisz; Piotr Witas; Magdalena Orzechowska; Andrzej K Bednarek
Journal:  J Appl Genet       Date:  2020-06-20       Impact factor: 3.240

Review 6.  Competing endogenous RNAs in lung cancer.

Authors:  Meilian Zhao; Jianguo Feng; Liling Tang
Journal:  Cancer Biol Med       Date:  2021-02-15       Impact factor: 4.248

7.  Long non‑coding RNA PRNCR1 exerts oncogenic effects in tongue squamous cell carcinoma in vitro and in vivo by sponging microRNA‑944 and thereby increasing HOXB5 expression.

Authors:  Cong Lin; Yanan Zou; Ruijing Li; Daofeng Liu
Journal:  Int J Mol Med       Date:  2020-04-16       Impact factor: 5.314

8.  Long non-coding RNA PRNCR1 has an oncogenic role in breast cancer.

Authors:  Qian Guo; Shuang Lv; Bingping Wang; Yinbing Li; Nier Cha; Ruigang Zhao; Wenhua Bao; Baoqing Jia
Journal:  Exp Ther Med       Date:  2019-10-31       Impact factor: 2.447

Review 9.  Long non-coding RNAs as the critical factors during tumor progressions among Iranian population: an overview.

Authors:  Zahra Rahmani; Majid Mojarrad; Meysam Moghbeli
Journal:  Cell Biosci       Date:  2020-01-14       Impact factor: 7.133

10.  Long noncoding RNA VPS9D1-AS1 augments the malignant phenotype of non-small cell lung cancer by sponging microRNA-532-3p and thereby enhancing HMGA2 expression.

Authors:  Xiao Han; Tianren Huang; Junqing Han
Journal:  Aging (Albany NY)       Date:  2020-01-05       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.